Everyone in healthcare is trying to figure out wearables, including pharma. Omnicom Health Group is counting on a new digital health partnership to help its…

They say there’s no such thing as a free lunch, and for doctors fed by drug companies, the old adage might be true, a JAMA study found.

Diabetes researchers, endocrinologists and primary care docs, patient advocacy groups and, of course, media descended on New Orleans to catch the latest. Here…

Eli Lilly has been racking up new Trulicity data to build a broader case for the weekly GLP-1 med, and a new study now shows that adding it to Lantus beat…

The super-pricey rare disease med Soliris fell short in a key myasthenia gravis trial, putting Alexion's ambitions for the new use in doubt. But top…

CHICAGO--The ASCO annual meeting is the biopharma version of Cannes or Sundance: Non-stop premieres, news conferences, sideline interviews and more. Track this…

Coming soon: Artificial intelligence-powered ads that can chat. Think IBM’s Watson engine, with ads powered to answer “conversational queries like ‘is this…

Payers and healthcare systems seeking reprieve from growing cancer costs had better buckle in. According to a new report, a record number of debut meds will…

Data and Analytics